Drug conjugate comprising drug linked to human c-Met antibody, and use therefor
US9364556B2 · kind B2 · utility
2Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 28, 2012 |
| Grant date | Jun 14, 2016 |
| Priority date | — |
| Expiry date | Nov 28, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a drug conjugate comprising a cytotoxic drug conjugated to a c-Met specific human antibody. More specifically, the present invention relates to: a drug conjugate comprising a cytotoxic drug conjugated to a c-Met specific human antibody; a pharmaceutical composition for cancer treatment comprising the drug conjugate; and a cancer treatment method comprising a step in which the drug conjugate or pharmaceutical composition is administered to an individual.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.